ACE2 and malignant colon neoplasm: In patients with colon cancer, ACE2 expression tended to increase with disease progression (Figure 3A), whereas TMPRSS2 levels were not significantly altered in the lesions (Supplementary Figure 2A); however, patients with high levels of ACE2 displayed good prognosis compared to those with low expression (Figure 3B).